Content related to New Phase 1 Clinical Trial to Test Durvalumab in Pediatric Patients
Can a Tiny Fish Transform Treatment for Childhood Cancers?
October 13, 2021
A physician-scientist is harnessing the power of zebrafish—and a new, state-of-the-art facility—to develop innovative treatments for solid tumors in children.
New Faculty Spotlight: Sarah Richman, MD, PhD
August 31, 2021
Sarah Richman, MD, PhD Cancer and Blood Disease Institute Sarah Richman, MD, PhD, investigates the use of chimeric antigen receptor (CAR) T-cell therapy for solid tumors. She and others in the field
Combination Therapy May Offer Better Outcomes for Patients with Retinoblastoma
April 19, 2016
Cultured retinoblastoma tumor containing tumor cells (red) and fibroblasts (green). Researchers at The Saban Research Institute of Children’s Hospital Los Angeles (CHLA) have demonstrated that
The Many Faces of Coronavirus and COVID-19 Research
July 20, 2020
From basic research to epidemiological data, investigators in The Saban Research Institute of Children’s Hospital Los Angeles are taking on COVID-19 research from multiple directions.
Making it Personal: How Genetic Technologies are Changing the Face of Medicine
June 13, 2019
The age of one-size-fits-all medicine is fading. Taking its place is an era of personalized medicine – the practice of tailoring disease prevention, diagnosis, and treatment to patients as individuals
Cell Therapy Program Expands
February 15, 2021
With the addition of four scientists, the team is developing new and innovative approaches to CAR-T therapy in children.
A Partnership Is Making a 'Huge Impact' on Childhood Cancer
May 16, 2021
5 Questions for Jeri Wilson, Executive Director of the Pediatric Cancer Research Foundation
Treatment Significantly Reduces Chemotherapy-Induced Hearing Loss in Children
December 6, 2016
Investigators from Children’s Hospital Los Angeles and 37 other Children’s Oncology Group hospitals in the U.S. and Canada have determined that sodium thiosulfate prevents cisplatin-induced hearing
Stay Up to Date
Sign up to receive our monthly newsletter, latest news, events and stories delivered right to your inbox.